- Home
- TOPS vs ALGS Comparison
TOPS vs ALGS Comparison
Compare TOPS & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- ALGS
- Stock Information
- Founded
- TOPS 2000
- ALGS 2018
- Country
- TOPS Greece
- ALGS United States
- Employees
- TOPS N/A
- ALGS 70
- Industry
- TOPS Marine Transportation
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- TOPS Consumer Discretionary
- ALGS Health Care
- Exchange
- TOPS Nasdaq
- ALGS Nasdaq
- Market Cap
- TOPS 26.6M
- ALGS 27.9M
- IPO Year
- TOPS 2004
- ALGS 2020
- Fundamental
- Price
- TOPS $5.82
- ALGS $5.36
- Analyst Decision
- TOPS
- ALGS Strong Buy
- Analyst Count
- TOPS 0
- ALGS 1
- Target Price
- TOPS N/A
- ALGS $70.00
- AVG Volume (30 Days)
- TOPS 9.3K
- ALGS 184.5K
- Earning Date
- TOPS 04-29-2025
- ALGS 05-06-2025
- Dividend Yield
- TOPS N/A
- ALGS N/A
- EPS Growth
- TOPS N/A
- ALGS N/A
- EPS
- TOPS 1.09
- ALGS N/A
- Revenue
- TOPS $86,127,000.00
- ALGS $3,945,000.00
- Revenue This Year
- TOPS $9.90
- ALGS $580.86
- Revenue Next Year
- TOPS N/A
- ALGS N/A
- P/E Ratio
- TOPS $5.21
- ALGS N/A
- Revenue Growth
- TOPS 3.83
- ALGS N/A
- 52 Week Low
- TOPS $5.30
- ALGS $3.76
- 52 Week High
- TOPS $14.24
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- TOPS 46.00
- ALGS 33.94
- Support Level
- TOPS $5.60
- ALGS $4.33
- Resistance Level
- TOPS $5.85
- ALGS $5.67
- Average True Range (ATR)
- TOPS 0.27
- ALGS 0.78
- MACD
- TOPS -0.01
- ALGS 0.43
- Stochastic Oscillator
- TOPS 39.64
- ALGS 49.61
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The company focuses on the transportation of petroleum products (clean and dirty) and bulk liquid chemicals. The Company is an international provider of worldwide oil, petroleum products and chemical transportation services. It generates revenue from the Time Charter agreements.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.